<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03342157</url>
  </required_header>
  <id_info>
    <org_study_id>17.120</org_study_id>
    <nct_id>NCT03342157</nct_id>
  </id_info>
  <brief_title>Docusate/Senna for the Treatment of Diabetic Gastroparesis</brief_title>
  <official_title>Pilot Study for the Efficacy and Tolerability of Senokot-S in the Treatment of Diabetic Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurora Health Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurora Health Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the efficacy of the stimulant laxative Senokot-SÂ® for the&#xD;
      treatment of diabetic gastroparesis. Senokot-S, and its metabolites, are thought to produce&#xD;
      peristalsis, drive intraluminal fluid and electrolyte shifts, and have an irritant effect on&#xD;
      the gut mucosa. These complex physiologic mechanisms appear may sufficiently promote stomach&#xD;
      emp-tying, and thereby reduce or eliminate the severity of gastroparesis symptoms. In this&#xD;
      open label study, participants will be randomized into high and low dose groups to assess for&#xD;
      ideal dosing and tolerability. It is the overall goal of this study to select the most&#xD;
      promising dose-strength for the treatment of mild through severe gastroparesis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    low enrollment&#xD;
  </why_stopped>
  <start_date type="Actual">April 2, 2018</start_date>
  <completion_date type="Actual">August 17, 2018</completion_date>
  <primary_completion_date type="Actual">August 17, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Gastroparesis Cardinal Symptom Index-Daily Diary (mGCSI-DD)</measure>
    <time_frame>28 days</time_frame>
    <description>mGCSI-DD uses 6-point Likert scale from 0 (none) to very severe (5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of Use of Breakthrough Medication</measure>
    <time_frame>28 days</time_frame>
    <description>Change in the frequency of use of breakthrough medication - daily diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of Bowel Movements</measure>
    <time_frame>28 days</time_frame>
    <description>Change in the frequency of bowel movements - daily diary</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Diabetic Gastroparesis</condition>
  <arm_group>
    <arm_group_label>High-dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8.6/50 mg of senna/docusate, oral, twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8.6/50 mg of senna/docusate, oral, once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>senna/docusate</intervention_name>
    <description>Stimulant laxative</description>
    <arm_group_label>High-dose</arm_group_label>
    <arm_group_label>Low-dose</arm_group_label>
    <other_name>Senokot-S</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-75 years, male and non-pregnant, non-lactating females&#xD;
&#xD;
          -  Diagnosis of type 1 or type 2 diabetes mellitus&#xD;
&#xD;
          -  Clinical diagnosis of diabetic gastroparesis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosed idiopathic gastroparesis&#xD;
&#xD;
          -  A history or inflammatory bowel disease, such as Crohn's disease or ulcerative colitis&#xD;
&#xD;
          -  A history of bowel obstruction, current unexplained abdominal pain, or undiagnosed&#xD;
             rectal bleeding&#xD;
&#xD;
          -  Gastrointestinal cancer&#xD;
&#xD;
          -  Any active cancer&#xD;
&#xD;
          -  Prior gastric surgery&#xD;
&#xD;
          -  End-stage heart disease, liver disease, lung disease&#xD;
&#xD;
          -  Known or suspected drug abuse&#xD;
&#xD;
          -  Any condition requiring use of daily narcotics&#xD;
&#xD;
          -  Concurrent usage of mineral oil or products containing mineral oil&#xD;
&#xD;
          -  Current or recent (within the last 3 months) usage of Senokot-S, docusate or senna&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley Gose, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aurora Health Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aurora Health Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>November 10, 2017</study_first_submitted>
  <study_first_submitted_qc>November 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2017</study_first_posted>
  <results_first_submitted>September 25, 2020</results_first_submitted>
  <results_first_submitted_qc>September 25, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 23, 2020</results_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bismuth subsalicylate</mesh_term>
    <mesh_term>Sennosides</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 29, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT03342157/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 23, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT03342157/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment occurred from 11/01/2017 through 05/11/2020 at St Lukes Medical Center utilizing outpatient and inpatient referrals from practitioners.</recruitment_details>
      <pre_assignment_details>No enrolled participants were excluded from the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>High-dose</title>
          <description>8.6/50 mg of senna/docusate, oral, twice daily&#xD;
senna/docusate: Stimulant laxative</description>
        </group>
        <group group_id="P2">
          <title>Low-dose</title>
          <description>8.6/50 mg of senna/docusate, oral, once daily&#xD;
senna/docusate: Stimulant laxative</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High-dose</title>
          <description>8.6/50 mg of senna/docusate, oral, twice daily&#xD;
senna/docusate: Stimulant laxative</description>
        </group>
        <group group_id="B2">
          <title>Low-dose</title>
          <description>8.6/50 mg of senna/docusate, oral, once daily&#xD;
senna/docusate: Stimulant laxative</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1"/>
                    <count group_id="B2" value="1"/>
                    <count group_id="B3" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1"/>
                    <count group_id="B2" value="1"/>
                    <count group_id="B3" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" lower_limit="51" upper_limit="51"/>
                    <measurement group_id="B2" value="49" lower_limit="49" upper_limit="49"/>
                    <measurement group_id="B3" value="50" lower_limit="49" upper_limit="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1"/>
                    <count group_id="B2" value="1"/>
                    <count group_id="B3" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1"/>
                    <count group_id="B2" value="1"/>
                    <count group_id="B3" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>modified gastroparesis cardinal symptom index daily diary (mGCSI-DD)</title>
          <description>Statistical analysis not appropriate on a sample size of 1.</description>
          <population>Statistical analysis not appropriate on a sample size of 1.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>breakthrough medication use</title>
          <description>Statistical analysis not appropriate on a sample size of 1.</description>
          <population>Statistical analysis not appropriate on a sample size of 1.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>frequency of bowel habits</title>
          <description>Statistical analysis not appropriate on a sample size of 1.</description>
          <population>Statistical analysis not appropriate on a sample size of 1.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Modified Gastroparesis Cardinal Symptom Index-Daily Diary (mGCSI-DD)</title>
        <description>mGCSI-DD uses 6-point Likert scale from 0 (none) to very severe (5)</description>
        <time_frame>28 days</time_frame>
        <population>Statistical analysis not appropriate on a sample size of 1 patient per arm.</population>
        <group_list>
          <group group_id="O1">
            <title>High-dose</title>
            <description>8.6/50 mg of senna/docusate, oral, twice daily&#xD;
senna/docusate: Stimulant laxative</description>
          </group>
          <group group_id="O2">
            <title>Low-dose</title>
            <description>8.6/50 mg of senna/docusate, oral, once daily&#xD;
senna/docusate: Stimulant laxative</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Gastroparesis Cardinal Symptom Index-Daily Diary (mGCSI-DD)</title>
          <description>mGCSI-DD uses 6-point Likert scale from 0 (none) to very severe (5)</description>
          <population>Statistical analysis not appropriate on a sample size of 1 patient per arm.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Use of Breakthrough Medication</title>
        <description>Change in the frequency of use of breakthrough medication - daily diary</description>
        <time_frame>28 days</time_frame>
        <population>Statistical analysis not appropriate on a sample size of 1 patient per arm.</population>
        <group_list>
          <group group_id="O1">
            <title>High-dose</title>
            <description>8.6/50 mg of senna/docusate, oral, twice daily&#xD;
senna/docusate: Stimulant laxative</description>
          </group>
          <group group_id="O2">
            <title>Low-dose</title>
            <description>8.6/50 mg of senna/docusate, oral, once daily&#xD;
senna/docusate: Stimulant laxative</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Use of Breakthrough Medication</title>
          <description>Change in the frequency of use of breakthrough medication - daily diary</description>
          <population>Statistical analysis not appropriate on a sample size of 1 patient per arm.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Bowel Movements</title>
        <description>Change in the frequency of bowel movements - daily diary</description>
        <time_frame>28 days</time_frame>
        <population>Statistical analysis not appropriate on a sample size of 1 patient per arm.</population>
        <group_list>
          <group group_id="O1">
            <title>High-dose</title>
            <description>8.6/50 mg of senna/docusate, oral, twice daily&#xD;
senna/docusate: Stimulant laxative</description>
          </group>
          <group group_id="O2">
            <title>Low-dose</title>
            <description>8.6/50 mg of senna/docusate, oral, once daily&#xD;
senna/docusate: Stimulant laxative</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Bowel Movements</title>
          <description>Change in the frequency of bowel movements - daily diary</description>
          <population>Statistical analysis not appropriate on a sample size of 1 patient per arm.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>35 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>High-dose</title>
          <description>8.6/50 mg of senna/docusate, oral, twice daily&#xD;
senna/docusate: Stimulant laxative</description>
        </group>
        <group group_id="E2">
          <title>Low-dose</title>
          <description>8.6/50 mg of senna/docusate, oral, once daily&#xD;
senna/docusate: Stimulant laxative</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>study stopped due to low enrollment</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Bradley Gose</name_or_title>
      <organization>Advocate Aurora Health</organization>
      <phone>414-385-2590</phone>
      <email>bradley.gose@aah.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

